Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
Authors
Keywords
Shigella, Shigella flexneri 2a, Vaccine, Bioconjugate vaccine, Controlled human challenge study
Journal
EBioMedicine
Volume 66, Issue -, Pages 103310
Publisher
Elsevier BV
Online
2021-04-15
DOI
10.1016/j.ebiom.2021.103310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
- (2019) John D Anderson et al. Lancet Global Health
- Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays
- (2019) Robert W Kaminski et al. CLINICAL INFECTIOUS DISEASES
- Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
- (2019) Kawsar R Talaat et al. CLINICAL INFECTIOUS DISEASES
- Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
- (2019) Calman A MacLennan et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic-Resistant Enteric Infections
- (2019) Sadia Shakoor et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Shigellosis
- (2018) Karen L Kotloff et al. LANCET
- Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score
- (2018) Chad K. Porter et al. PLoS One
- Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants
- (2018) Megumi Inoue et al. Human Vaccines & Immunotherapeutics
- Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study
- (2018) Elizabeth T Rogawski et al. Lancet Global Health
- Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
- (2017) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
- (2016) Ligia A. Pinto et al. JOURNAL OF INFECTIOUS DISEASES
- Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
- (2016) Jie Liu et al. LANCET
- Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
- (2015) Christoph F.R Hatz et al. VACCINE
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
- (2015) James A Platts-Mills et al. Lancet Global Health
- Effects of Shigella-, Campylobacter- and ETEC-associated Diarrhea on Childhood Growth
- (2014) Gwenyth Lee et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Shigella human challenge model
- (2012) C. K. PORTER et al. EPIDEMIOLOGY AND INFECTION
- Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of Life
- (2012) Gerwin D. Rodenburg et al. PLoS One
- Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
- (2010) Justen H. Passwell et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now